nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—CHRNG—tongue—amyotrophic lateral sclerosis	0.0593	0.15	CbGeAlD
Decamethonium—BCHE—diaphragm—amyotrophic lateral sclerosis	0.0529	0.134	CbGeAlD
Decamethonium—CHRNA1—tongue—amyotrophic lateral sclerosis	0.0392	0.0994	CbGeAlD
Decamethonium—HRH3—hindbrain—amyotrophic lateral sclerosis	0.0372	0.0943	CbGeAlD
Decamethonium—HRH3—brainstem—amyotrophic lateral sclerosis	0.0213	0.054	CbGeAlD
Decamethonium—CHRNG—medulla oblongata—amyotrophic lateral sclerosis	0.0182	0.046	CbGeAlD
Decamethonium—HRH3—nervous system—amyotrophic lateral sclerosis	0.0112	0.0283	CbGeAlD
Decamethonium—HRH3—central nervous system—amyotrophic lateral sclerosis	0.0108	0.0273	CbGeAlD
Decamethonium—HRH3—cerebellum—amyotrophic lateral sclerosis	0.0105	0.0266	CbGeAlD
Decamethonium—CHRNB1—medulla oblongata—amyotrophic lateral sclerosis	0.00928	0.0235	CbGeAlD
Decamethonium—HRH3—brain—amyotrophic lateral sclerosis	0.00854	0.0216	CbGeAlD
Decamethonium—CHRNB1—spinal cord—amyotrophic lateral sclerosis	0.00828	0.021	CbGeAlD
Decamethonium—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.00805	0.0204	CbGeAlD
Decamethonium—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.0075	0.019	CbGeAlD
Decamethonium—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.00722	0.0183	CbGeAlD
Decamethonium—ACHE—spinal cord—amyotrophic lateral sclerosis	0.00718	0.0182	CbGeAlD
Decamethonium—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.00705	0.0179	CbGeAlD
Decamethonium—CHRNA1—brain—amyotrophic lateral sclerosis	0.0069	0.0175	CbGeAlD
Decamethonium—CHRNB1—cerebellum—amyotrophic lateral sclerosis	0.00656	0.0166	CbGeAlD
Decamethonium—CHRNA2—brain—amyotrophic lateral sclerosis	0.00573	0.0145	CbGeAlD
Decamethonium—ACHE—cerebellum—amyotrophic lateral sclerosis	0.00569	0.0144	CbGeAlD
Decamethonium—BCHE—brainstem—amyotrophic lateral sclerosis	0.00567	0.0144	CbGeAlD
Decamethonium—CHRNB1—brain—amyotrophic lateral sclerosis	0.00533	0.0135	CbGeAlD
Decamethonium—CHRNE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00479	0.00792	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00463	0.00765	CbGpPWpGaD
Decamethonium—ACHE—brain—amyotrophic lateral sclerosis	0.00462	0.0117	CbGeAlD
Decamethonium—CHRNE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00458	0.00757	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00454	0.0075	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0045	0.00744	CbGpPWpGaD
Decamethonium—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00447	0.0113	CbGeAlD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00435	0.00719	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00431	0.00712	CbGpPWpGaD
Decamethonium—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.0043	0.0109	CbGeAlD
Decamethonium—CHRNE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00424	0.007	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00419	0.00692	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00419	0.00692	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00419	0.00692	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00419	0.00692	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00401	0.00663	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00398	0.00657	CbGpPWpGaD
Decamethonium—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.00396	0.01	CbGeAlD
Decamethonium—CHRNE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00394	0.00651	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00394	0.00651	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00394	0.0065	CbGpPWpGaD
Decamethonium—ACHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00387	0.00639	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00373	0.00617	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00373	0.00617	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0037	0.00612	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0037	0.00611	CbGpPWpGaD
Decamethonium—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00367	0.00606	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00358	0.00591	CbGpPWpGaD
Decamethonium—BCHE—spinal cord—amyotrophic lateral sclerosis	0.00353	0.00893	CbGeAlD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00351	0.00581	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00351	0.0058	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00351	0.0058	CbGpPWpGaD
Decamethonium—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00345	0.0057	CbGpPWpGaD
Decamethonium—CHRM2—brain—amyotrophic lateral sclerosis	0.00342	0.00865	CbGeAlD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00341	0.00564	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00327	0.0054	CbGpPWpGaD
Decamethonium—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00327	0.0054	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00324	0.00536	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00315	0.0052	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00307	0.00508	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00304	0.00502	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00304	0.00502	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00304	0.00502	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00299	0.00494	CbGpPWpGaD
Decamethonium—BCHE—nervous system—amyotrophic lateral sclerosis	0.00297	0.00753	CbGeAlD
Decamethonium—ACHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00293	0.00484	CbGpPWpGaD
Decamethonium—ACHE—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00289	0.00478	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00289	0.00477	CbGpPWpGaD
Decamethonium—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00286	0.00725	CbGeAlD
Decamethonium—CHRND—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00284	0.00469	CbGpPWpGaD
Decamethonium—BCHE—cerebellum—amyotrophic lateral sclerosis	0.0028	0.00708	CbGeAlD
Decamethonium—HRH3—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00279	0.00461	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00278	0.0046	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00274	0.00453	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00271	0.00448	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.0027	0.00446	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00264	0.00437	CbGpPWpGaD
Decamethonium—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00261	0.00432	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00261	0.00432	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00259	0.00427	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00259	0.00427	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00251	0.00414	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00248	0.0041	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00246	0.00406	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00246	0.00406	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00245	0.00404	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00241	0.00399	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00241	0.00398	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00233	0.00385	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00233	0.00385	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00233	0.00385	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0023	0.00381	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00229	0.00379	CbGpPWpGaD
Decamethonium—BCHE—brain—amyotrophic lateral sclerosis	0.00227	0.00575	CbGeAlD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00222	0.00367	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00221	0.00366	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00219	0.00362	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00213	0.00352	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00208	0.00343	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00204	0.00338	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00202	0.00334	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.002	0.00331	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00199	0.00329	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00198	0.00327	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00198	0.00327	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00195	0.00323	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00188	0.00311	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00188	0.00311	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00185	0.00306	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00182	0.00301	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00181	0.00299	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00179	0.00295	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00179	0.00295	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00177	0.00292	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00169	0.00279	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00168	0.00277	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00165	0.00273	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00163	0.0027	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00161	0.00266	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00159	0.00263	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00159	0.00262	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00154	0.00254	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00152	0.00251	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00152	0.00251	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.00149	0.00246	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00146	0.00241	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00145	0.0024	CbGpPWpGaD
Decamethonium—ACHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00145	0.00239	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00142	0.00234	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00141	0.00234	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00137	0.00227	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00137	0.00226	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00137	0.00226	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00137	0.00226	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00136	0.00224	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00136	0.00224	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00135	0.00224	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00135	0.00223	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00133	0.0022	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00129	0.00214	CbGpPWpGaD
Decamethonium—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00129	0.00213	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00127	0.00209	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00126	0.00209	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00126	0.00208	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00126	0.00208	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00126	0.00208	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00125	0.00207	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00125	0.00207	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00125	0.00207	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00122	0.00202	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00122	0.00202	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00122	0.00201	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00121	0.002	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0012	0.00199	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.00192	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00116	0.00192	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00113	0.00187	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00112	0.00185	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00112	0.00185	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00104	0.00172	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00104	0.00172	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00104	0.00172	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00104	0.00171	CbGpPWpGaD
Decamethonium—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00101	0.00167	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00101	0.00167	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000969	0.0016	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000967	0.0016	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000955	0.00158	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000926	0.00153	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000926	0.00153	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.000907	0.0015	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.000902	0.00149	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000901	0.00149	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000868	0.00144	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000867	0.00143	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000855	0.00141	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000815	0.00135	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000778	0.00129	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000775	0.00128	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000763	0.00126	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000738	0.00122	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000721	0.00119	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000719	0.00119	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000706	0.00117	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000706	0.00117	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000676	0.00112	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000658	0.00109	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000651	0.00108	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000646	0.00107	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000642	0.00106	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000635	0.00105	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00063	0.00104	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00063	0.00104	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000612	0.00101	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000602	0.000995	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0006	0.000992	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000587	0.00097	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000583	0.000964	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000576	0.000952	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000564	0.000932	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000549	0.000908	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000546	0.000902	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000535	0.000885	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000529	0.000875	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000518	0.000856	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000512	0.000846	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.00051	0.000843	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000503	0.000832	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000455	0.000752	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000452	0.000747	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000439	0.000725	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000428	0.000708	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000417	0.000689	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000407	0.000673	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000403	0.000666	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000396	0.000654	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000387	0.000639	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000378	0.000625	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000357	0.00059	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000352	0.000582	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000346	0.000571	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000345	0.00057	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00033	0.000545	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000325	0.000538	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000325	0.000537	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000318	0.000526	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000315	0.00052	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000314	0.000519	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00031	0.000513	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000293	0.000484	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00029	0.000479	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000282	0.000466	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000276	0.000456	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000269	0.000445	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000267	0.000442	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000261	0.000432	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000261	0.000432	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000253	0.000418	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00024	0.000396	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000239	0.000394	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000224	0.000369	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00022	0.000363	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000208	0.000344	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000207	0.000341	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000196	0.000324	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000191	0.000316	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00019	0.000313	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000183	0.000303	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000172	0.000284	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.00017	0.000282	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000168	0.000278	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000167	0.000275	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000163	0.00027	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000158	0.00026	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000145	0.000239	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000141	0.000232	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000139	0.00023	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000135	0.000224	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000132	0.000219	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000129	0.000213	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000125	0.000207	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000123	0.000203	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000119	0.000197	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000114	0.000189	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000112	0.000186	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000107	0.000177	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000106	0.000176	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000102	0.000169	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.75e-05	0.000145	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.49e-05	0.00014	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.22e-05	0.000136	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.16e-05	0.000135	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.28e-05	0.00012	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.27e-05	0.00012	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.77e-05	0.000112	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.59e-05	9.24e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.3e-05	7.11e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.07e-05	6.72e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.65e-05	6.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.76e-05	4.56e-05	CbGpPWpGaD
